BIO commends the Government of India for recognizing the critical role that intellectual property plays in innovation and for initiating...
March 6 2015
The Biotechnology Industry Organization (BIO) appreciates the opportunity to participate in the Special 301...
February 9 2015
Therapeutic biologics are an opportunity to address unmet patient needs, drive innovation, and assist China's transformation into a...
July 10 2013
Biologics are complex medicines that are manufactured using living organisms. Due to their size and complexity, biologics are...
July 8 2013
BIO represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations...
June 19 2013
Countries across the globe are realizing the significant impact rare diseases have on their populations, and are responding by putting...
June 7 2013
BIO commends the Government of Peru for its endeavor to create a pathway for the approval of biological and biotechnological products....
March 21 2013
BIO commends the government of Colombia for taking steps towards developing regulatory requirements for the registry of medicines of...
February 22 2013
BIO commends the INPI for their efforts to devise guidelines for examining biotechnology related inventions. Given the technological...
February 1 2013
The House Judiciary Committee conducted a hearing on World IP Day on "International Patent Issues: Promoting...
April 25 2012
The vast majority of BIO’s members are small and medium sized enterprises that currently do not have products...
March 7 2012
BIO has identified the following countries of interest and recommends the following for our 2011 Special 301 submission.
February 14 2012
By Electronic Submission
Office of Policy and External Affairs
United States Patent and Trademark Office...
November 10 2011
Re: Request for Comments on the Strategy for American Innovation
Subject: Innovation Strategy RFI
April 1 2011
I'm writing on behalf of the Biotechnology Industry Organization (BIO) in response to your invitation for public comments on...
June 22 2007
Perhaps no other industry is as dependent upon patents as is the biotech industry. In 2004 alone, more than 10% of the PTO's...
October 6 2006
Dear House Leadership:
On behalf of the Biotechnology Industry Organization (BIO), I urge you to seek prompt passage of H.R. 1561, the...
October 24 2003
Under Secretary of Commerce for Intellectual Property and Director of the USPTO on Patent Harmonization
May 6 2002
May 6 2002
May 6 2002
Acting Undersecretary of Commerce and Acting Director of the United States Patent and Trademark Office Regarding Patent Law Harmonization
May 4 2001